Theravance Biopharma
TBPH
#6360
Rank
โ‚น81.92 B
Marketcap
Country
โ‚น1,578
Share price
0.00%
Change (1 day)
0.58%
Change (1 year)

EPS for Theravance Biopharma (TBPH)

EPS in 2026 (TTM): โ‚น94.15

According to Theravance Biopharma 's latest financial reports the company's current EPS (TTM) is โ‚น98.22. In 2025 the company made an earnings per share (EPS) of โ‚น193.66 an increase over its 2024 EPS that were of -โ‚น106.56.

EPS history for Theravance Biopharma from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น94.15-51.38%
2025โ‚น193.66-281.74%
2024-โ‚น106.5618.56%
2023-โ‚น89.88-108.41%
2022โ‚น1,069-491.19%
2021-โ‚น273.35-34.15%
2020-โ‚น415.125.16%
2019-โ‚น394.736.5%
2018-โ‚น370.64-26.61%
2017-โ‚น505.0028.24%
2016-โ‚น393.81
2014-โ‚น688.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Corcept Therapeutics
CORT
โ‚น138.99 41.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Collegium Pharmaceutical
COLL
โ‚น113.05 15.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น167.71 70.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-โ‚น586.54-697.17%๐Ÿ‡บ๐Ÿ‡ธ USA